PRIVACY POLICY

This Privacy Policy is designed to inform you about the ways in which we, ThromboGenics, Inc., (“ThromboGenics”), intend to collect, use, and disclose information that you may provide via this Web site. Please be advised that this policy applies only to personal information collected from ThromboGenics online resources. It does not apply to third-party online resources linked to from this Web site, as ThromboGenics has no control over the content of such resources.

This Web site is governed by applicable United States federal and state laws, and any relevant government regulations. By using this Web site, you not only agree to be bound by the terms of this Policy, but also acknowledge that these laws and regulations apply to you. You also consent to the collection and use of information as set forth in this Policy.

You should carefully read this entire Policy before using and/or submitting information on this Web site.

  1. Information Collected.
    1. Information You Provide.
      Registration may be necessary to access certain portions of our Web site. When registering to use our Web site or its features and services, or to receive emails or other communications from ThromboGenics, you will be asked to provide identifying information. This may include such information as your name, gender, email address, mailing address, and health information. Information that is required for registration will be clearly labeled and distinguished from information that is optional and may be given at your discretion. We may also collect personal information from you through your participation in the interactive services available on our Web site, including surveys, questionnaires, comment forms, and submissions related to employment opportunities. Additional information may also be required if you wish to obtain additional services or information, or to resolve complaints or concerns. Any personal information you provide to ThromboGenics by email (eg, when you ask questions or report problems with our products) will also be collected. If you communicate with or request information from ThromboGenics personnel, they will retain your email address as well as any health-related and/or personal facts you chose to include in your email communication. If you are reporting an experience or reaction involving one of our products, we may ask you for additional information pursuant to our reporting obligations under existing federal regulations. If you are a medical professional and are using the Web site for reasons other than reporting a product experience, you should make sure that you do not disclose identifiable information about your patients without a valid authorization. Any personal information that you voluntarily post on bulletin boards, chat rooms, forums, or other public areas (“Public Areas”) of this Web site will not be protected by this Privacy Policy. ThromboGenics does not control the use and disclosure of any information posted on such Public Areas. Please do not post any information in a Public Area that you do not wish to be disclosed to the general public and used without limitation.
    2. Information Collected Routinely.
      Visitors to our Web site can access the site’s home page, and browse some areas of the site without disclosing any personally identifiable information. However, we do track information provided to us by your browser, including the Web site you came from, the type of browser you use, the time and date of access, and other information that does not personally identify you. In addition, we gather information about you that is automatically collected by our Web server, such as your IP address and domain name.
    3. Information From Outside Sources.
      We may collect information from other sources about physicians or other health care professionals who register on our Web site in order to verify their licensure status and identity. We also may ask users for information after they register, such as credit card information for processing of a purchase order. In these instances, we may contact financial or credit organizations to confirm whether the credit card information provided is accurate.
  2. Use of Data.
    1. General.
      Information about your use of the services and activities on our Web site will be used to track user traffic patterns so that we can tailor our products and services to better serve you. Your personal information will be used to respond to your questions, provide information about the Web site, and/or inform you of significant changes to this Policy. We may also use your personal information to create customized offers, information, and services tailored to your interests and preferences, and to send you emails with special newsletters or other information that we think may be of interest to you. You are responsible for ensuring the accuracy of any personal information you provide through our Web site. If your information is outdated or inaccurate, we may not be able to respond to your emails or notify you about changes to this Privacy Policy. Please note that you can choose to opt out of receiving these emails or unsubscribe to newsletters at any time.
    2. Product Experiences.
      If you contact ThromboGenics regarding your personal experiences with one of our pharmaceutical products (investigational or marketed), we may use this information in submitting reports to the U.S. Food and Drug Administration (“FDA”) pursuant to existing federal regulations. We may also use and disclose the information you provide to our product’s clinical investigators in order to follow up on any unexpected events arising from the use of our products.
    3. Career Opportunities.
      If you contact ThromboGenics with employment inquiries or other related communications, we may use any personal information you provide to (i) send you an email confirming receipt of your application; (ii) contact you if we need more information related to your employment application, account profile, or employment search; (iii) process your employment application; (iv) respond to your questions; and (v) contact you about other employment positions that may be of interest to you. We may also use and disclose your personal information, account profile, resume, and any other information provided to third parties in order to evaluate your eligibility for any employment opportunity with ThromboGenics, including the performance of background verifications with third-party vendors.
  3. Disclosure of Information.
    ThromboGenics will not sell or otherwise disclose any personal information we collect about or from you through our Web site to any third parties without your consent, except as set forth below.

    1. Legal or Safety Reasons. 
      We may disclose your personal information to third parties: (1) to comply with valid legal requirements such as a law, regulation, search warrant, subpoena or court order; (2) in certain instances in which we believe it is reasonably necessary to investigate or prevent harm, fraud, abuse, or illegal conduct; or (3) where needed for corporate audits or to investigate or respond to a complaint or security threat. We also reserve the right to cooperate with law enforcement authorities in disclosing information for the purpose of investigating and prosecuting users who violate our policies or engage in behavior that is illegal or harmful to other Web sites. If we are legally compelled to disclose your personal information to a third party, we will notify you of this fact, unless doing so would violate the law or court order or pose a threat or danger to you or others. In addition, we will take all necessary steps to ensure that the requester understands the sensitive nature of any information so provided.
    2. Operations and Maintenance Contractors. 
      Third parties that ThromboGenics contracts with to maintain or service the Web site or other aspects of our business will sometimes have access to your personal information in the course of providing products or services to the company. These contractors may include, but are not limited to, our Webmasters, attorneys, auditors, and vendors who are hired to analyze the data collected on our Web site. Any third-party contractor’s access to your personal information will be limited to the minimum information reasonably necessary for the contractor to perform its limited function for the company.
    3. Aggregate Information. 
      We may provide nonpersonal, nonidentifying information about you to third parties, and that information may be combined in aggregate with the information of other users for statistical purposes. For example, we might inform third parties of the number of people who use our Web site, and what activities they engage in while browsing our site.
  4. Links to Other Sites.
    Our Web site may, on occasion, feature links to Web sites sponsored by other companies that we believe you might find useful and informative. However, ThromboGenics does not endorse or recommend the content or services of these third party sites, and does not have any control over these Web sites. This Privacy Policy, therefore, does not apply to those Web sites. If you choose to visit one of these third-party sites, you should carefully read the privacy policy of that site to understand how your personal information will be collected and used by it.
  5. Information Security.
    Please be assured that ThromboGenics has physical, electronic, and managerial procedures in place to safeguard the personal information you have provided to us via our Web site. Our technology and security policies, rules, and other measures are designed to protect your personal data from unauthorized access, improper use, alteration, unlawful or accidental destruction, and accidental loss. We use industry standard firewalls and password protection to prevent unauthorized individuals from accessing information. We also require that all our employees and any others who have access to or are associated with the processing of your data respect your confidentiality. Keep in mind, however, that any passwords, ID numbers, or other special access numbers you might use to access any part of this site are your responsibility, so you must safeguard them carefully. You should take steps to ensure that the computer you are using is adequately secured and protected against malicious software. Without adequate security measures (eg, secure Web browser configuration, up-to-date antivirus software, personal firewall software, no usage of software from dubious sources) there is a risk that the data and passwords you use to protect access to your data on our Web site could be disclosed to unauthorized third parties.
  6. Children’s Policy.
    This Web site is not intended or designed to attract children under the age of 13. We do not collect personally identifiable information from any person we know to be under the age of 13 without the prior, verifiable consent of his or her legal representative. Such legal representative has the right, upon request, to view the information provided by the child and/or to require that it be deleted.
  7. Changes to the Privacy Policy.
    ThromboGenics may periodically change, modify, add, remove, or otherwise update this Policy at its discretion, without prior notification. However, any changes to this Policy will be posted on this page so that you are fully informed of the types of information we are gathering, how we use it, and under what circumstances it may be disclosed.

Indication

JETREA® (ocriplasmin) injection, for Intravitreal Injection, 1.25 mg/mL is a proteolytic enzyme indicated for the treatment of
symptomatic vitreomacular adhesion.

Important Safety Information

Warnings and Precautions

  • A decrease of ≥ 3 lines of best-corrected visual acuity (BCVA) was experienced by 5.6% of patients treated with JETREA and 3.2% of patients treated with vehicle in the controlled trials. The majority of these decreases in vision were due to progression of the condition with traction and many required surgical intervention. Patients should be monitored appropriately.
  • Intravitreal injections are associated with intraocular inflammation/infection, intraocular hemorrhage and increased intraocular pressure (IOP). Patients should be monitored and instructed to report any symptoms without delay. In the controlled trials, intraocular inflammation occurred in 7.1% of patients injected with JETREA vs 3.7% of patients injected with vehicle. Most of the post-injection intraocular inflammation events were mild and transient. If the contralateral eye requires treatment with JETREA, it is not recommended within 7 days of the initial injection in order to monitor the post-injection course in the injected eye.
  • Potential for lens subluxation.
  • In the controlled trials, the incidence of retinal detachment was 0.9% in the JETREA group and 1.6% in the vehicle group, while the incidence of retinal tear (without detachment) was 1.1% in the JETREA group and 2.7% in the vehicle group. Most of these events occurred during or after vitrectomy in both groups.
  • Dyschromatopsia (generally described as yellowish vision) was reported in 2% of all patients injected with JETREA. In approximately half of these dyschromatopsia cases there were also electroretinographic (ERG) changes reported (a- and b-wave amplitude decrease).

Adverse Reactions

  • The most commonly reported reactions (≥ 5%) in patients treated with JETREA were vitreous floaters, conjunctival hemorrhage, eye pain, photopsia, blurred vision, macular hole, reduced visual acuity, visual impairment, and retinal edema.

Please see full Prescribing Information for JETREA.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch or call 1-800-FDA-1088. You may also report side effects of JETREA online directly to ThromboGenics by clicking here if you are a Patient or here if you are a Health Care Professional.